A Preventive Blood Patch Reduced Spinal Headaches After Pain Pump Implants

A Preventive Blood Patch Reduced Spinal Headaches After Pain Pump Implants

By Ivan Urits, MD – Board Certified in Anesthesiology and Pain Medicine

Published September 8, 2026 | Category: Pain Medicine

Implanting an intrathecal pain pump requires placing a catheter through the dura, the membrane around the spinal fluid. Spinal fluid can then leak, causing a severe headache that worsens when sitting or standing. Patients with advanced cancer may heal poorly because of malnutrition and illness. A 2026 multicenter study in Frontiers in Neurology looked at whether a preventive epidural blood patch, an injection of the patient's own blood near the puncture site, reduces these problems.

This summary is based on the published abstract. Read the abstract on PubMed

What the authors did

The authors reviewed patients with hard-to-control cancer pain who had pump implants between January 2023 and August 2025. Some received a blood patch of 10 to 15 mL during surgery. Others received standard conservative care: bed rest for 24 to 48 hours, IV fluids and caffeine. Patients were matched to balance the two groups, giving 78 pairs (156 patients).

What they found

  • Moderate-to-severe postural headache: 6.4% with the blood patch vs 25.6% without. About 5 patients would need a patch to prevent one such headache.
  • Spinal fluid leaks seen on imaging: 7.7% vs 24.4%.
  • Need for a later rescue blood patch: 2.6% vs 15.4%.
  • Headaches were shorter, and hospital stays were shorter, in the blood patch group.
  • Minor side effects occurred in 11.5% of patients who received a patch. No spread of cancer cells to the spinal area was seen over about 3 months of follow-up.

Why this matters

For patients with advanced cancer, a severe headache and extra days in bed or in the hospital are a real burden, and a later rescue patch is another procedure. A preventive step during the original surgery may spare many patients these problems.

Limitations

This was a retrospective study, so unmeasured differences between groups may have affected results. Follow-up was short, and long-term safety, including the theoretical risk of spreading cancer cells, needs confirmation. The authors call for randomized trials.

Safety takeaways: how to apply it

For pain physicians and procedure teams

  • Discuss spinal fluid leak risk with patients before pump implant, especially frail patients with cancer.
  • Consider a preventive blood patch in carefully selected high-risk patients, weighing infection and other risks.
  • Monitor for postural headache after implant, and have a plan for treatment.

For hospitals, clinics and safety leaders

  • Track headaches, leaks and rescue patches after pump implants as quality measures.

For patients and families

  • Report a headache that worsens when sitting or standing after a pump implant.

Reference

  1. Zhang A, Chen Y, Li Q, Ning Z, Wang H, Pan H, et al. Prophylactic epidural blood patch for cerebrospinal fluid leakage after intrathecal drug delivery system implantation in patients with refractory cancer pain: a multi-center retrospective cohort study. Front Neurol. 2026;17:1883156. doi:10.3389/fneur.2026.1883156. PMID: 42534469. PubMed: https://pubmed.ncbi.nlm.nih.gov/42534469/

This article is educational information, not legal or medical advice.

Previous
Previous

Two Everyday Safety Questions: Steroid Preservatives and Swabbing Vial Tops

Next
Next

Epidural Hematoma After Spine Procedures: Act on Pain, Don’t Wait for Weakness